NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Sartorius Stedim Biotech S.A (PA: DIM)

 
DIM Technical Analysis
4
As on 24th Jul 2025 DIM STOCK Price closed @ 175.25 and we RECOMMEND Sell for LONG-TERM with Stoploss of 196.54 & Strong Sell for SHORT-TERM with Stoploss of 247.62 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

DIMSTOCK Price

Open 175.75 Change Price %
High 177.00 1 Day 2.40 1.39
Low 172.05 1 Week -21.25 -10.81
Close 175.25 1 Month -27.75 -13.67
Volume 68004 1 Year -78.55 -30.95
52 Week High 280.00 | 52 Week Low 145.35
 
PA France Most Active Stocks
ALALO 0.00 %
ALNRG 0.01 %
ALBOO 0.00 %
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ALEUP 0.00 %
ALRPD 0.01 0.00%
ALVER 0.00 %
ORA 13.30 1.37%
DSY 29.31 -8.38%
 
PA France Top Gainers Stocks
MLFTI 0.03 50.00%
ALTHE 0.56 33.33%
SIGHT 0.15 15.38%
ALMUN 0.94 14.63%
ALBPS 0.16 14.29%
VLA 3.33 10.63%
VLA 3.33 10.63%
ALLLN 1.40 10.24%
ALEO2 2.64 10.00%
MLEDR 47.80 9.13%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
MLPRX 0.20 -16.67%
RF 55.70 -13.84%
RF 55.70 -13.84%
ALMAR 0.79 -12.22%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
ALUVI 2.93 -10.67%
 
 
DIM
Daily Charts
DIM
Intraday Charts
Whats New @
Bazaartrend
DIM
Free Analysis
 
DIM Important Levels Intraday
RESISTANCE184.79
RESISTANCE181.73
RESISTANCE179.84
RESISTANCE177.95
SUPPORT172.55
SUPPORT170.66
SUPPORT168.77
SUPPORT165.71
 
DIM Forecast July 2025
4th UP Forecast347.23
3rd UP Forecast292.08
2nd UP Forecast257.98
1st UP Forecast223.89
1st DOWN Forecast126.61
2nd DOWN Forecast92.52
3rd DOWN Forecast58.42
4th DOWN Forecast3.27
 
DIM Weekly Forecast
4th UP Forecast199.72
3rd UP Forecast191.87
2nd UP Forecast187.02
1st UP Forecast182.17
1st DOWN Forecast168.33
2nd DOWN Forecast163.48
3rd DOWN Forecast158.63
4th DOWN Forecast150.78
 
DIM Forecast2025
4th UP Forecast448.69
3rd UP Forecast361
2nd UP Forecast306.79
1st UP Forecast252.59
1st DOWN Forecast97.91
2nd DOWN Forecast43.71
3rd DOWN Forecast-10.5
4th DOWN Forecast-98.19
 
 
DIM Other Details
Segment EQ
Market Capital 43451432960.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website >
 
DIM Address
DIM
 
DIM Latest News
 
Your Comments and Response on Sartorius Stedim Biotech S.A
 
DIM Business Profile
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG. Address: Zone Industrielle Les Paluds, Aubagne, France, 13781
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service